Research integrity in the COVID-19 era: insights from Retraction Watch co-founder Ivan Oransky
Read Ivan Oransky’s take on the retraction landscape and his perspectives on how to tackle research integrity issues in the future.
The future of data sharing: insights from PLOS’ Director, Open Research Solutions
Data sharing is crucial for reproducibility. Iain Hrynaszkiewicz shares his thoughts on how publishers can promote its uptake.
Overcoming barriers to reporting negative data: perspectives from the Center for Biomedical Research Transparency’s founder
Sandra Petty discusses the Null Hypothesis Initiative and looks to the future of reporting negative data.
Improving reproducibility in scientific research: insights from the UK Reproducibility Network
Professor Marcus Munafò discusses the importance of reproducibility in scientific research and how we can overcome barriers to achieving it.
Meeting report: summary of session 2 of the 8th EMWA Symposium
Missed the meeting? Read our report on the symposium entitled “Research integrity & the medical communicator: what we do when no one is watching.”
Meeting report: summary of session 1 of the 8th EMWA Symposium
Missed the meeting? Read our report on the symposium entitled “Research integrity & the medical communicator: what we do when no one is watching.”
How research can be shared effectively to advance science: insights from the Center for Open Science
David Mellor from the Center for Open Science explains how the company is supporting and facilitating the open science movement.
Researchers call for better adoption of open science in COVID-19 research
Researchers identify flaws in current COVID-19 research and publication processes, and provide solutions using Open Science principles
SPENT: new guidelines for reporting n-of-1 trial protocols
An extension and elaboration of the SPIRIT checklist specific to n-of-1 trials aims to improve the quality and reporting of protocols for this trial type.
Will standardised research data policies make publishing more FAIR?
The Research Data Alliance has published standardised research data policies, but wider collaboration is needed to ensure they are supported and implemented.
The TOP Factor: a new journal metric to assess transparency and reproducibility policies
Find out more about the TOP Factor, an alternative metric to the impact factor, evaluating academic journals based on open science policies.
Successes and challenges in data sharing: insights from the YODA Project
With widespread and growing support for increased data sharing, what can we learn from the Yale Open Data Access (YODA) Project and its collaboration with Johnson & Johnson?
Negative results can have a positive impact, but only if they are available!
The reproducibility crisis is linked to publication bias and a paucity of negative data. Find out how and why to get such data published.
The link between data sharing and citation counts
An analysis of data sharing statements reveals that open data may lead to a citation advantage.
Are we delivering on transparency and reproducibility?
Transparency and reproducibility are now synonymous with medical publications, but actions speak louder than words. A recent study examines whether progress has been made.
Increasing quality and transparency of preclinical data: an opportunity for publication professionals?
An article in the MAP newsletter examines how publication professionals could help to increase preclinical publishing standards.